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Background: Although chicken anemia virus (CAV) has been detected on all continents, little is known about this
virus in sub-Saharan Africa. This study aimed to detect and characterize CAV for the first time in Central African
Republic and in Cameroon.
Results: An overall flock seroprevalence of 36.7% was found in Central African Republic during the 2008–2010
period. Virus prevalences were 34.2% (2008), 14.3% (2009) and 10.4% (2010) in Central African Republic and 39%
(2007) and 34.9% (2009) in Cameroon. CAV DNA was found in cloacal swabs of 76.9% of seropositive chickens,
suggesting that these animals excreted the virus despite antibodies. On the basis of VP1 sequences, most of the
strains in Central African Republic and Cameroon belonged to 9 distinct phylogenetic clusters at the nucleotide
level and were not intermixed with strains from other continent. Several cases of mixed infections in flocks and
individual chickens were identified.
Conclusions: Our results suggest multiple introductions of CAV in each country that later spread and diverged
locally. Mixed genotype infections together with the observation of CAV DNA in cloacal samples despite antibodies
suggest a suboptimal protection by antibodies or virus persistence.
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Chicken anemia virus (CAV), the only member of the
Gyrovirus genus in the Circoviridae family [1], was first
discovered in the late 70’s [2], but a retrospective study
revealed that the virus circulated in chickens long before
that [3]. Chickens are considered the only natural host
of chicken anemia virus, although anti-CAV antibodies
have also been detected in Japanese quails [4] but not in
other domestic or wild bird species [4,5]. CAV is ubiqui-
tous [6] and the virus seems to be particularly well
adapted to its host [7].
The fecal-oral route constitutes probably the main
mode of horizontal transmission [8], but CAV was also
detected in feather shafts indicating that other modes of
dissemination may be possible [9]. Experimental* Correspondence: claude.muller@crp-sante.lu
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reproduction in any medium, provided the orinfections via the respiratory tract were also successful
[10] but the relevance of such experiments in the field is
still unclear. The virus can also be transmitted vertically
from infected parents, either the male or female [11,12],
irrespective of their antibody status [11,13,14], to their
progeny. Seroconversion of specific pathogen-free chick-
ens around the onset of lay without detectable virus in
the flock suggested that CAV could be maintained in re-
productive organs as a latent or persistent infection with
low levels of replication, and become reactivated when
the animal reaches sexual maturity [7,11,15].
The virus causes severe anemia, pale bone marrow,
thymus atrophy and severe immunosuppression in 2–
3 weeks old chickens if they are not protected by mater-
nal antibodies [7]. In older animals infections usually re-
sult in subclinical disease that can also lead to economic
losses in poultry farms due to reduced weight gain and
increased susceptibility to secondary infections [16-19].
Co-infections with Marek’s disease virus or infectious
bursal disease virus (IBDV) may lead to a more complex
and severe disease [20,21].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.virologyj.com/content/9/1/189Although the poultry sector is an important part of
the economy in many African countries, CAV has only
been reported without further details from South Africa
[22] and more detailed studies were done by us and
others in Nigeria [23-27]. In this study, we describe for
the first time the presence and the genetic diversity of




In Bangui (CAF), anti-CAV antibodies were found in
147 chicken sera out of the 400 analyzed. In farms,
36.7% (29/79) of the flocks had at least one chicken with
anti-CAV antibodies and there was little change
throughout the 3 years of sampling: 34.8% (8/23) in
2008, 39.3% (11/28) in 2009 and 35.7% (10/28) in 2010
(Table 1). Four flocks had a seroprevalence below 25%, 5
flocks had a seroprevalence between 25 and 50%, and 20
flocks had a seroprevalence above 50% (Table 1). Most
seropositive flocks for which the age was available be-
came seropositive after week 5 (Figure 1A). Several
farms were visited 2 or 3 times but no trend could be
seen when comparing percentage of seropositive animals
between collection time points. In the 2 live bird mar-
kets where sera were collected, 69% (68/98) of chickens
were seropositive and the seroprevalence in each market
was 67.9% (38/56) and 71.4% (30/42).
Virus prevalence
In CAF, CAV nucleic acids were detected in 45.8% (11/
24) of the flocks in 2008, in 31.7% (19/60) in 2009 and
in 15% (9/60) in 2010 (Table 2). Fourteen flocks had a
prevalence below 25%, 7 flocks had a prevalence be-
tween 25 and 50%, and 18 flocks had a prevalence above
50% (Table 2). Similarly to the seroprevalence data, no
trend in the percentage of virus infected animals was
observed over the time in farms visited several times.
CAV was also detected in 21.2% (42/198) of samples col-
lected in live bird markets and 3 of the 5 markets were
infected (prevalence of 27.8% (30/108), 15.5% (11/71)
and 9.1% (1/11) over 21 months). For 400 animals, seraTable 1 Seroprevalence in flocks from Central African
Republic
Year Seroprevalence (%) Total








2008 15 1 1 2 4 23
2009 17 1 1 1 8 28
2010 18 2 3 3 2 28
Total 50 4 5 6 14 79
Seroprevalence is expressed as the number of flocks with a seroprevalence
included in a percentage range.and swabs were available and 76.9% (113/147) of the
antibody positive animals were PCR positive while all
antibody negative animals (253/400) were PCR negatives.
Overall prevalences of CAV infections of 34.2% (26/
76), 14.3% (59/412) and 10.4% (33/316) were found in
2008, 2009 and 2010 respectively in Central African
Republic, compared to 39% (112/287) in 2007 and 34.9%
(203/582) and 2009 in Cameroon.
In both countries, a total of 433 samples were positive
for CAV nucleic acids and were submitted for
sequencing.
Phylogenetic analyses of nucleotide sequences
Sequencing of the VP1 coding region was attempted for
all CAV positive samples but only 228 sequences of at
least 1281 nucleotides from the 433 positive samples
were obtained. The phylogeny of these 228 VP1 gene
sequences (1281 bp) revealed several clusters within
group II or III in both countries (Figure 2). The 53 VP1
sequences from 20 chicken flocks and 3 live bird
markets in Bangui formed 4 groups (CAF1 to CAF4;
Figures 2 and 3). CAF1 strains were very similar to each
other (maximal Kimura distance mKd 0.5%) and 1 strain
CAF09-144 clustered outside CAF1 group (mKd 0.9% to
CAF1). The CAF1 strains were most closely related to
strains from Argentina, 2007–2008 (Figure 3). The
CAF2 group consisted of only 2 strains (mKd 2.1%) that
formed an isolated cluster within group II (Figure 3).
Twenty-five strains formed the CAF3 group (mKd 0.8%;
Figure 3). The CAF4 group contained 8 strains and was
as diverse as CAF2 (mKd 2.1%), but the clustering of
CAF09-153 was uncertain as shown by the discrepancies
in the trees of Figures 2 and 3. All groups contained
strains from farms and live bird markets, except CAF2
which contained strains from markets only. All strains
from 2008 clustered in CAF1 and CAF3; 2009 strains
were found in all groups and 2010 strains in CAF1 to 3.
One hundred seventy-five sequences from chickens in
Cameroon clustered in 5 main groups (CMR1 to CMR5;
Figures 2 and 4). CMR1 cluster included 104 strains
from both 2007 and 2009 (mKd 1.4%), and a Nigerian
strain CAV/Ejioku.NIE/11.02/107 (Figure 4A). CMR2
contained 11 strains from 2009 (mKd 0.2%; Figure 4B)
and was most closely related to a Japanese strain and to
the CAF3 cluster (Figure 2). The CMR3 group included
35 strains from 2009 (mKd 0.9%) and was most closely
related to a Chinese strain CH_CK/05-01/HN/592
(Figure 4B). In addition, 1 strain CMR09-565.1 clustered
outside CMR3 group (mKd to CMR3 of 1.3%; Figure 2).
CMR4 cluster contained 21 very similar strains from
2007 only (mKd 0.2%). Two strains from 2009 clustered
in CMR5 (mKd 0.1%; Figure 4B), and one strain
(CMR09-314) clustered with Argentinean strains but did










































Figure 1 Anti-CAV antibody seroprevalence in CAF. (A) Age-dependent seroprevalence in broiler flocks (●) and layer flocks (□) in CAF and in
broiler (Δ) or pullet and layer (x) flocks in Nigeria (from Owoade et al. [27]). (B) Relation between seroprevalence and virus DNA prevalence in
chicken flocks in CAF
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After cloning, sequences of the clones were compared to
the original electropherograms of the (uncloned) sample
showing signs of mixed infection. The electropherogram
of the original sample and the clones matched in all cases,
confirming in two independent sequencing experimentsTable 2 Virus prevalence in flocks from Central African
Republic
Year Virus prevalence (%) Total








2008 13 2 4 3 2 24
2009 41 6 3 4 6 60
2010 51 6 0 1 2 60
Total 105 14 7 8 10 144
Virus prevalence is expressed as the number of flocks with a virus prevalence
included in a percentage range.that the mixed infections were not due to contamination
during the amplification steps.
In Central African Republic, 6 flocks out of 20 from
which CAV sequences were obtained, contained strains
of 2 different genotypes (Table 3), either CAF1 and
CAF3, or CAF1 and CAF4 strains. CAF1 and CAF4
strains were also both found in 2 markets. In addition,
analyses of VP1 clones from samples with ambiguous
nucleotides revealed mixed infections in 6 individual
samples with the above combinations of genotypes
(CAF1 and CAF3, CAF1 and CAF4) as well as CAF2
and CAF3 (Figure 3). In 3 of these cases, both parental
strains were also found in other samples from the same
farm or market (Table 3).
Similarly, CAV VP1 sequences in 13 samples from
Cameroon out of 35 showing ambiguous nucleotides
were cloned. Analyses of clones showed that these




AM407852 CH_CK/05-01/HN/592 / China
HQ872029 JS-22 / China
CMR09-565.1
AM407827 CH_CK/05-05/GD/5258 / China
HQ872034 JS-78 / China
AM407817 CH_CK/05-01/GD/210 / China
DQ124935  AH6 / China
CMR5
AJ888527 CAV/Lagos.NIE/11.02/38 / Nigeria
AJ888528 CAV/Lanlate.NIE/11.02/71 / Nigeria
DQ016138 130 / Slovenia
AJ888524 CAV/Abeokuta.NIE/19.04/118 / Nigeria
AF395114   BD-3/Bengladesh
DQ016139 469 / Slovenia
DQ016140 69 / Slovenia
AY583756  CAV-B/Chicken / India 
AJ888525 CAV/Abeokuta.NIE/19.04/117 / Nigeria
CMR4
HM018724 09Q227 / South Korea
L14767 CIA-1 / USA
CAF4
CAF09-153
DQ141670  SH11 / China
AF390102   attenuated SMSC-1P60 / Malaysia
AJ890284 Nobilis P4 vaccine
D10068 26P4 / USA
AJ888529 CAV/Lanlate.NIE/11.02/12 / Nigeria
AF390038  3-1 / Malaysia
U69548 ConnB / USA
M55918 CUX1 / Germany
AY843527  TJBD33/China
AF527037 BL-5 / Malaysia
AY150576 attenuated BL-5P90 / Malaysia
AJ888523 CAV/Ikire.NIE/11.02/9 / Nigeria
AF313470 Del-Ros
DQ141671  SH16 / China
AM407870 CH_CK/05-05/GD/5262 / China
AM407825 CH_CK/05-04/GD/3592 / China
AM407843 CH_CK/05-05/GD/4960 / China
AY846844 TJBD40 / China
AF372658  CAV-15 / USA
CMR2
D31965 82-2 / Japan
CAF3
AM407879 CH_CK/04-12/GD/7616 / China
U69549 L-028 / USA
CAF2
CAF1
EU871782 Arg753 / Argentina
EU871767  Arg439 / Argentina
CMR09-314
EU871770 Arg609 / Argentina
EU871773  Arg513 / Argentina
EU871779 ArgA0018R / Argentina
CAF09-144
EU871776  Arg684 / Argentina
EU871780  ArgA0010_28 / Argentina
AB027470 TR20
U65414 Australia
AF285882  SMSC-1 / Malaysia
AM407851 CH_SCK/04-05/GD/3450 / China
AF311900  98D06073 / USA
AJ888521 CAV/Ibadan.NIE/14.04/116 / Nigeria

















































Figure 2 Phylogenetic analysis of partial VP1 sequences (1281
nucleotides) of 228 CAV strains from Central African Republic
(●) and Cameroon (▲). Sequences from mixed infected samples
are represented by the grey symbols. CAF and CMR clusters are
shown as aggregated clusters (CAF1-CAF4; CMR1-CMR5). Only











AJ890284 Nobilis P4 vaccine
DQ141670  SH11 / China
L14767 CIA-1 / USA
AF395114   BD-3/Bengladesh
AM407852 CH_CK/05-01/HN/592 / China
AM407827 CH_CK/05-05/GD/5258 / China
CAF09-153
AF313470 Del-Ros
M55918 CUX1 / Germany




























U69549 L-028 / USA
DQ124936  AH4 / China
AJ888522 CAV/Ejioku.NIE/11.02/107 / Nigeria
AB027470 TR20
CAF09-144
EU871779 ArgA0018R / Argentina
EU871776  Arg684 / Argentina
EU871767  Arg439 / Argentina
























































Figure 3 Detailed phylogenetic analyses of all strains from CAF
(53 strains). Fewer reference strains from GenBank were used in
comparison to Figure 2 due to figure size restrictions. Symbols are as
in Figure 2. Only bootstrap values≥ 50% are shown.




AM407852 CH_CK/05-01/HN/592 / China
CMR09-565.1
AM407827 CH_CK/05-05/GD/5258 / China
CMR5
AF395114   BD-3/Bengladesh
CMR4
L14767 CIA-1 / USA
AJ890284 Nobilis P4 vaccine
M55918 CUX1 / Germany
AF313470 Del-Ros
DQ141670  SH11 / China
D31965 82-2 / Japan
CMR2
III
U69549 L-028 / USA
EU871770 Arg609 / Argentina
CMR09-314
EU871767  Arg439 / Argentina
EU871779 ArgA0018R / Argentina
EU871776  Arg684 / Argentina
AB027470 TR20





















































































































































































AM407852 CH_CK/05-01/HN/592 / China
CMR09-565.1
AM407827 CH_CK/05-05/GD/5258 / China
CMR09-560
CMR09-569 CMR5























L14767 CIA-1 / USA
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M55918 CUX1 / Germany
AF313470 Del-Ros
DQ141670  SH11 / China














U69549 L-028 / USA
EU871770 Arg609 / Argentina
CMR09-314
EU871767  Arg439 / Argentina
EU871779 ArgA0018R / Argentina
EU871776  Arg684 / Argentina
AB027470 TR20





































Figure 4 Detailed phylogenetic analyses of CMR1 (A) and CMR 2 to 5 (B) strains from Cameroon (175 strains). Fewer reference strains
from GenBank were used in comparison to Figure 2 due to figure size restrictions. Symbols are as in Figure 2. Only bootstrap values≥ 50% are
shown.
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Table 3 Mixed infections in flocks, markets and in
individual samples from Central African Republic
Flock Sample Clusters
Flock 1 CAF08-044 CAF1 + CAF3
CAF08-045 CAF1




Flock 3 CAF08-072 CAF1
CAF08-074 CAF3
CAF08-075 CAF3
Flock 4 CAF08-076 CAF1 + CAF3
CAF08-078 CAF1 + CAF3
CAF08-079 CAF1
Flock 5 CAF09-131 CAF4
CAF09-132 CAF1
Flock 6 CAF09-144 -
CAF09-145 CAF1
CAF09-146 CAF1 + CAF3
CAF09-147 CAF3




Market 2 CAF09-142 CAF1
CAF09-143 CAF4










HQ872029 JS-22 / China






HQ872034 JS-78 / China
AM407852 CH_CK/05-01/HN/592 / China
AM407827 CH_CK/05-05/GD/5258 / China
L14767 CIA-1 / USA
HM018724 09Q227 / South Korea
AF311900 98D06073 / USA
DQ124935 AH6 / China
AM407851 CH_SCK/04-05/GD/3450 / China
AM407879 CH_CK/04-12/GD/7616 / China
AJ888527 CAV/Lagos.NIE/11.02/38 / Nigeria
AJ888528 CAV/Lanlate.NIE/11.02/71 / Nigeria
U69549 L-028 / USA
AF395114 BD-3 / Bengladesh
DQ016140 69 / Slovenia
DQ016139 469 / Slovenia
DQ016138 130 / Slovenia
AJ888524 CAV/Abeokuta.NIE/19.04/118 / Nigeria
CMR07-080
CMR07-003
AY583756 CAV-B/Chicken / India 
CMR07-004.1










DQ124936 AH4 / China
CMR07-216
CMR09-784.1
AJ888521 CAV/Ibadan.NIE/14.04/116 / Nigeria
AJ888522 CAV/Ejioku.NIE/11.02/107 / Nigeria
EU871770 Arg609 / Argentina
U65414 Australia
AB027470 TR20
EU871776 Arg684 / Argentina
CAF09-119.1
EU871773 Arg513 / Argentina
CAF08-044.2
EU871767 Arg439 / Argentina
CAF09-132
AF285882 SMSC-1 / Malaysia
CAF09-139
EU871779 ArgA0018R / Argentina
CAF08-076.2
EU871782 Arg753 / Argentina
CMR09-440
EU871780 ArgA0010_28 / Argentina
CMR09-630
DQ141670 SH11 / China
CAF09-116
CAF09-148.2
AF390038 3-1 / Malaysia
M55918 CUX1 / Germany
U69548 ConnB / USA
AJ888529 CAV/Lanlate.NIE/11.02/12 / Nigeria
D10068 26P4 / USA
AJ890284 Nobilis P4 vaccine
AY150576 attenuated BL-5P90 / Malaysia
AF227982 Australia
AF372658 CAV-15 / USA
AF527037 BL-5 / Malaysia









D31965 82-2 / Japan
DQ141671 SH16 / China
AY846844 TJBD40 / China
AM407825 CH_CK/05-04/GD/3592 / China
AM407843 CH_CK/05-05/GD/4960 / China











Figure 5 Phylogenetic analysis of the predicted amino acid
sequences. Representative strains from each CAF and CMR clusters
were used and all strains with amino acid substitutions compared to
a reference strain within the group were included. Symbols are as in
Figure 2. Only bootstrap values≥ 50% are shown.
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CMR4 and in 2009 with CMR1 and CMR3 strains or
with 2 distinct CMR1 strains (CMR09-784.1 and
CMR09-784.2) differing by 7 nucleotides (Figure 4).Table 4 Amino acid patterns in VP1 protein of the African
genomic groups
Cluster 22 75 97 139 144 287 290 370 413
CAF1 H I L Q Q T P S A
CAF2/CAF4 H V M Q Q S A G S
CAF3/CMR2 H V M K E S A G S
CMR1 H I L Q/K Q/E T A S A
CMR3/CMR5 N I L Q/K Q/E A A S A
CMR4 H I L Q Q A A T APhylogenetic analyses of amino acid sequences
At the amino acid level, the groups I to III defined at
the nucleotide level were less clearly distinguishable
(Figure 5). Nevertheless most of the CAF/CMR strains
still clustered with sequences of their own nucleotide se-
quence group sharing specific amino acid sequences
(Table 4), except for CMR09-440 (CMR1) and CMR09-
630 (CMR3), both of which clustered together with an
Argentinian strain (ArgA0010_28), as a result of Q139K
and Q144E mutations located in the hypervariable re-
gion. CAF2 and CAF4 sequences, CAF3 and CMR2, and
CMR3 and CMR5 sequences were identical at the amino
acid level as a result of synonymous mutations (Table 4).
All CAF/CMR clusters shared amino acids with publishedsequences except the CAF2/CAF4 group that had a
unique amino acid pattern (Table 4, Figure 5).
Sixteen unique amino acid substitutions were observed
in the strains from Central African Republic and Camer-
oon (R6L, R9K, F77L, G74E, S178P, G219E, S229Y,
I285V, S300N, M311I, K341R, Q351H, T361A, D366E,
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strains (L190M, T215A, V385I).Discussion
The overall flock seroprevalence of 36.7% in CAF
appeared to be lower than in most other developing
countries. In Nigeria, the only African country from
where such data are available, a flock seroprevalence of
55% was reported in 20 flocks including broilers, pullets,
cockerels and layers in the main hub of the poultry in-
dustry in the Southwest of the country [27]. Even a sero-
prevalence of 89% was reported later in chicken flocks of
4 to 12 months of age [24]. Also countries such as China
[28], Malaysia [29], Japan [4], India [30] and Hungary
[31] reported flock seroprevalences ranging from 66 to
100%. Normally the seroconversion is not homogeneous
within a flock and tends to increase with age, complicat-
ing comparisons between studies [5,32]. For instance
broiler flocks of 3 to 10 weeks have a similar seropreva-
lence in Nigeria (40%) [27] and in CAF (34%) and the
seroprevalence in the flocks ranges from 20 to 100% in
both countries (Figure 1A).
As in Nigeria, chickens are not vaccinated against
CAV in Central African Republic. All sampled flocks ex-
cept 2, were older than 2 to 3 weeks, the age at which
the maternal antibodies wane [5,19,33]. Thus the anti-
bodies detected are likely the result of a field infection
and are not maternally derived nor vaccine induced
antibodies.
Similar overall virus prevalences were found in 2007
and 2009 in Cameroon (39% and 34.9%) and in 2008 in
Central African Republic (34.2%). In 2009 and 2010, the
prevalence decreased to 14.3% and 10.4% in Central
African Republic. This trend to lower incidence rates in
Central African Republic may correspond to an
improved sensitivity to hygiene due to farmer awareness
in the aftermath of the first results of the study. The
above values were also surprisingly low compared to
other countries such as China (87%) [34], Malaysia
(80%) [29] and Argentina (49%) [35] but comparable to
Nigeria (41%) [23] for the 2007–2008 period. Although
the prevalence may vary with time, this may indicate
that the virus is less prevalent in sub-Saharan Africa
than in Asia or South America. Nevertheless, prevalence
rates of viral nucleic acids and antibodies may be under-
estimated in particular when the prevalence is low in a
flock and/or low numbers of chickens were analyzed per
flock. For instance, by analyzing 4 samples per flock, the
certainty of detecting antigens or antibodies in a infected
flock decreases from 93% when the prevalence is 50%, to
68% when the prevalence is 25%. A lower expected virus
prevalence in the digestive tract compared to lymphoid
organs [29], the relative young age of the animals, andpossibly co-infections with other pathogens may also
contribute to underestimate prevalence rates.
CAV DNA could be detected in cloacal samples of a
large majority (76.9%) of the seropositive chickens, indi-
cating that these animals may shed the virus despite
antibodies (Figure 1B). While antibodies normally de-
velop within 1 to 3 weeks [6,8,12,36], viral particles can
be detected in feces up to 5 to 7 weeks post infection
[8,12] suggesting that the virus is cleared with consider-
able delay after the development of virus-neutralizing
antibodies. If we assume that most chickens become
infected early after the waning of maternal antibodies,
persistence of virus may even be longer. This could ex-
plain the high prevalence of virus in seroconverted ani-
mals. Alternatively co-infections with very virulent
IBDV, which is also circulating in West and Central
Africa [37-39], may cause a delay in development
of anti-CAV antibodies, resulting in CAV persistence
and a prolonged viral shedding in feces [20]. Besides the
detection of a second round of viral infection cannot
be ruled out although the expected excretion period
would be short [12].
Although there is no clear geographic clustering of
CAV strains worldwide and despite the low mutation
rate at the amino acid level [21], most of the strains
sequenced in CAF and CMR belonged to 9 distinct clus-
ters at the nucleotide level and were not intermixed with
strains from other continent. This suggests multiple
introductions of CAV in Central Africa resulting in sev-
eral clusters that emerged locally and had time to spread
and diverge. Normally, chicks used to populate commer-
cial farms in CAF are imported from Europe, but
European strains (Germany, Slovenia) available in GenBank
are phylogenetically not the closest relatives.
In our study, 6 flocks contained more than 1 CAV
strain and 19 samples revealed mixed infections as con-
firmed by cloning. Similarly, cloning of VP1 sequences
from Nigeria [23] and the USA [40] revealed the pres-
ence of 2 different strains (belonging to groups II and
III) in the same sample. Sequences exhibiting ambiguous
nucleotides have also been found in China [34] and
Brazil [41] but these were not further investigated. Thus,
mixed infection by CAV strains may be a relatively com-
mon event, but its impact is currently unknown.
Conclusions
Despite the low (sero) prevalence found in Central
African Republic and Cameroon compared to other
countries, several clusters including only African strains
were found. This suggests multiple introductions of CAV
that spread and diverged locally. Mixed genotype infec-
tions together with the observation of CAV DNA in clo-
acal samples despite antibodies suggest a suboptimal
protection by antibodies or virus persistence.
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Sample cohorts
In the framework of enhanced laboratory surveillance
for avian viruses in the aftermath of avian influenza out-
breaks in West and Central Africa, an average of 4 (be-
tween 1 and 16) cloacal samples per flock (broilers or
layers) in 5 randomly selected farms were collected every
month between June 2008 and December 2010 (n= 606)
in Bangui (CAF). Cloacal swabs (n= 198) were also col-
lected in two live bird markets every month between
April 2009 and December 2010. In addition, 400 sera
from swabbed birds were collected. Whenever recorded
(in 73% of the flocks), the age of the animals ranged
from 18 to 68 days for broiler flocks and from 8 weeks
to 3 years for layer flocks.
In Cameroon, 287 cloacal swabs and 582 pooled
tracheal-cloacal swabs from chicken were collected in
2007 (January to June) and 2009 (April to June) respect-
ively in farms only (2007) or in farms and live bird mar-
kets (2009) within a 50 km radius around the town of
Bamenda, North West Region. The age of the animals
was not recorded.
Enzyme-linked immunosorbent assay (ELISA)
A commercial competitive ELISA kit (FlockCheckW
CAV, IDEXX, Hoofddorp, The Netherlands) was used to
detect specific antibodies against CAV in chicken sera
(n= 400) at a 1:10 dilution. Sera samples were collected
from birds in farms (n= 302) and live bird markets
(n= 98). Optical density was measured using a Multiskan
Ascent reader (Thermo Labsystems, Helsinki, Finland)
at 650 nm. Sample to negative (S/N) ratios were calcu-
lated for each sample and samples with S/N ratios ≤ 0.60
were considered positive.
Nucleic acid extraction, polymerase chain reactions
All swabs were discharged in 500 μl of virus transport
medium (VTM) containing 2000 U/ml penicillin,
200 mg/ml streptomycin, 2000 U/ml polymyxin B,
250 mg/ml gentamycin, 60 mg/ml ofloxacin, 200 mg/ml
sulfamethoxazole and 2.5 mg/ml amphotericin B.
Nucleic acids were extracted from 140μl of VTM using
QIAamp Viral RNA Mini Kit (Qiagen, Venlo, The
Netherlands). Extracted nucleic acids were screened for
CAV DNA in a nested PCR format using previously
published primers [11]. The equivalent of 2.5μl of nu-
cleic acids and 0.5μl of first round PCR products were
used in the first round and nested PCRs respectively.
PCR reactions were carried out using the following cyc-
ling conditions: initial denaturation at 95°C for 5 min,
40 cycles of amplification at 95°C for 30 s, 54°C (1st
round) or 60°C (nested) for 30 s, 72°C for 1 min, and a
final extension at 72°C for 10 min. PCR products were
visualized by gel electrophoresis.The certainty C of detecting CAV in an infected flock
for various flock sizes N and various prevalences P was
calculated according to the formula of Cannon and Roe
(1982, cited by [42]): n ¼ 1  1  Cð Þ1=PxNxsens
n o
N 0:5 PxN 1ð Þf g assuming an average number of
n= 4 samples collected per flock and a test sensitivity
(sens) of 100%.
Sequencing
A fragment containing the entire VP1 coding region
(nucleotides 1 to 1350) of the positive samples was ampli-
fied as 3 partially overlapping fragments with a total length
of 1389 bp (from nucleotide −33 to nucleotide 1355) using
several primer combinations [23]. Sequencing of purified
PCR products was performed as previously described [34].
Sequence assembly and analyses were performed using
SeqScape version 2.5 (Applied Biosystems, Nieuwerkerk,
The Netherlands) and BioEdit [43]. The 5’ end of the VP1
coding region (69 nucleotides) was not reliably sequenced
for a few strains. Therefore a shorter fragment (1281
nucleotides) was used in the phylogenetic analyses in order
to include as many strains as possible.
Cloning
Samples exhibiting ambiguous determination of nucleotides
at various positions caused by clear double peaks in the
electropherogram were further analyzed. The VP1 frag-
ments of 1370 bp were generated starting from the original
DNA sample using primers OS1F and S3R7 (1st round
PCR; nucleotides −117 to 1355) and S1F and S3R1
(5’-CCCAGTACATSGTGCTGTT-3’) primers (nested
PCR; nucleotides −33 to 1336), purified and cloned using
the TOPO TA cloning kit (Life Technologies, Merelbeke,
Belgium) as described previously [23]. Ten to 24 colonies
were selected and inserts were sequenced with M13 pri-
mers (Life Technologies). To exclude the possibility of
crosscontamination, long amplicons (1370 bp) suitable for
cloning were generated twice in two independent experi-
ments (on different days) and were cloned separately (again
on different days) for two samples and similar results were
obtained. Both experiments gave clones of the same
sequences although with different frequencies.
Phylogenetic analyses
Genetic distances were calculated with MEGA v5.03 [44]
according to the Kimura 2-parameters model. Phylogenetic
relationships were inferred by comparing the African
strains with all CAV DNA sequences available on GenBank
(downloaded in February 2012) after removal of short
sequences and sequences with insertions or deletions
resulting in frame shifts. Datasets were aligned using Clus-
talW [45]. Trees were calculated with the Neighbour-
Joining method, using the Kimura 2-parameters model and
Snoeck et al. Virology Journal 2012, 9:189 Page 9 of 10
http://www.virologyj.com/content/9/1/1891000 bootstrap replicates for the nucleotide tree and with
the Poisson model for the amino acid tree (MEGA v5.03;
data not shown). Reference strains from GenBank were
selected based on these preliminary analyses. Trees includ-
ing the selected reference strains from GenBank and all
(Figure 2) or a subset (Figure 5) of the sequences generated
in this study were calculated using the same parameters as
described above. Fewer representative strains from
GenBank were used in Figures 3 and 4 due to figure size
restrictions. All gene sequences can be found under acces-
sion numbers [EMBL: HE662876 to HE663056 and
HE686970 to HE687016]. Strains were designated using the
following nomenclature: 3-letter country code (CAF =
Central African Republic; CMR = Cameroon)_year-sample
number (last 3 digits). Sequences from mixed infected sam-
ples are named by adding .1 or .2 after the strain name.
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